Mindset to Participate in the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th
November 29, 2021 07:30 ET
|
Mindset Pharma Inc.
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating...
Mindset Pharma Announces Poster Presentation of Preclinical Data for Benchmarking Next-Generation Psychedelics at Neuroscience 2021
November 08, 2021 07:30 ET
|
Mindset Pharma Inc.
TORONTO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating...
Mindset Pharma Reports Fiscal Year 2021 Financial Results and Provides Corporate Update
October 26, 2021 17:00 ET
|
Mindset Pharma Inc.
--Evolving Pipeline of Psychedelics Compounds Focused on Improved Efficacy and Safety Advancing MSP-1014 as First Lead Drug Clinical Candidate to IND-Enabling Studies Developing...
Mindset Pharma to Participate in Wonderland: Miami on November 8-9, 2021
October 26, 2021 07:30 ET
|
Mindset Pharma Inc.
TORONTO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating...
Mindset Pharma Expands Benchmarking Data for First Generation Psychedelics Through the COPE Program with InterVivo Solutions
October 14, 2021 07:30 ET
|
Mindset Pharma Inc.
TORONTO, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating...
Mindset Pharma Expands Pipeline: Identifies Additional Next Generation 5-MeO-DMT-Inspired Lead Candidates
September 29, 2021 07:30 ET
|
Mindset Pharma Inc.
TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating...
Mindset Pharma Announces Inclusion in NYSE Listed AdvisorShares Psychedelics Exchange Traded Fund (ETF)
September 23, 2021 07:30 ET
|
Mindset Pharma Inc.
TORONTO, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating...
Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and Improved Safety Profile for its 5-MeO-DMT-Inspired Drug Candidate, MSP-4018
September 20, 2021 07:30 ET
|
Mindset Pharma Inc.
TORONTO, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating...
Mindset Pharma Further Validates Lead Candidate, MSP-1014, as a Next Generation Psilocybin Analog through Drug Discrimination Assay
September 14, 2021 07:30 ET
|
Mindset Pharma Inc.
TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating...
Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its Novel Psilocybin-Inspired Clinical Candidate
September 09, 2021 08:50 ET
|
Mindset Pharma Inc.
TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating...